cisplatin

Topotecan in cervical cancer
S. Ackermann, M. W. Beckmann, F. Thiel, T. Bogenrieder

International Journal of Gynecologic Cancer Oct 2007, 17 (6) 1215-1223; DOI: 10.1111/j.1525-1438.2007.01003.x
Galectin-3 may contribute to Cisplatin resistance in clear cell carcinoma of the ovary
T. Oishi, H. Itamochi, J. Kigawa, Y. Kanamori, M. Shimada, M. Takahashi, R. Shimogai, W. Kawaguchi, S. Sato, N. Terakawa

International Journal of Gynecologic Cancer Sep 2007, 17 (5) 1040-1046; DOI: 10.1111/j.1525-1438.2007.00916.x
A meta-analysis of the efficacy of intraperitoneal cisplatin for the front-line treatment of ovarian cancer
L. M. Hess, M. Benham-Hutchins, T. J. Herzog, C.-H. Hsu, D. C. Malone, G. H. Skrepnek, M. K. Slack, D. S. Alberts

International Journal of Gynecologic Cancer May 2007, 17 (3) 561-570; DOI: 10.1136/ijgc-00009577-200705000-00003
Cytoreduction and intraperitoneal heated chemotherapy for the treatment of endometrial carcinoma recurrent within the peritoneal cavity
C. W. Helm, C. R. Toler, R. S. Martin, M. E. Gordinier, L. P. Parker, D. S. Metzinger, R. P. Edwards

International Journal of Gynecologic Cancer Jan 2007, 17 (1) 204-209; DOI: 10.1111/j.1525-1438.2006.00751.x
Telomerase antisense inhibition for the proliferation of endometrial cancer in vitro and in vivo
X. J. Chen, W. Zheng, L. L. Chen, Z. B. Chen, S. Q. Wang

International Journal of Gynecologic Cancer Oct 2006, 16 (6) 1987-1993; DOI: 10.1111/j.1525-1438.2006.00734.x
A phase I study of concurrent cisplatin chemotherapy in patients with carcinoma of the cervix receiving pelvic radiotherapy
C. Nyongesa, P. Ruff, B. Donde, J. Kotzen

International Journal of Gynecologic Cancer Jul 2006, 16 (4) 1614-1619; DOI: 10.1136/ijgc-00009577-200607000-00020
Phase II study of tirapazamine plus cisplatin in patients with advanced or recurrent cervical cancer
F. C. Maluf, A. L. Leiser, C. Aghajanian, P. Sabbatini, S. Pezzulli, D. S. Chi, J. K. Wolf, C. Levenback, E. Loh, D. R. Spriggs

International Journal of Gynecologic Cancer Apr 2006, 16 (3) 1165-1171; DOI: 10.1136/ijgc-00009577-200605000-00033
Combined adjuvant cisplatin and ifosfamide chemotherapy and radiotherapy for malignant mixed müllerian tumors of the uterus
L. Wong, H. T. See, H. S. Khoo-Tan, J. S. Low, W. T. Ng, J. J. Low

International Journal of Gynecologic Cancer Apr 2006, 16 (3) 1364-1369; DOI: 10.1136/ijgc-00009577-200605000-00063
Analysis of differential protein expression by cisplatin treatment in cervical carcinoma cells
E. K. Yim, K. H. Lee, C. J. Kim, J. S. Park

International Journal of Gynecologic Cancer Mar 2006, 16 (2) 690-697; DOI: 10.1136/ijgc-00009577-200603000-00038
Ras antagonist inhibits growth and chemosensitizes human epithelial ovarian cancer cells
M. E. Beiner, H. Niv, R. Haklai, G. Elad-Sfadia, Y. Kloog, G. Ben-Baruch

International Journal of Gynecologic Cancer Jan 2006, 16 (Suppl 1) 200-206; DOI: 10.1136/ijgc-00009577-200602001-00032

Main menu

cisplatin

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

cisplatin

Pages